medfinecapital.com
#30,310,411
Global Rankeez rank
Better than 69.8% of the 100,511,422 domains we track
Best rank recorded
#30,310,411
2026-11
Worst rank recorded
#30,323,376
2026-07
Tracked since
2026-07
4 monthly snapshots
Source breakdown
Rankeez combines several independent public rankings. Here's how medfinecapital.com scores in each:
| Source | Rank |
|---|---|
| CommonCrawl (hyperlink graph) | #29,437,490 |
See how these sources are combined and cross-validated →
Ranking history
medfinecapital.com's rank across 4 monthly snapshots. ▲ improved by 12,965 since 2026-07
| Month | Rank |
|---|---|
| 2026-07 | #30,323,376 |
| 2026-08 | #30,316,058 |
| 2026-10 | #30,312,202 |
| 2026-11 | #30,310,411 |
JSON API
{
"medfinecapital.com": 30310411,
"history": {
"2026-07": 30323376,
"2026-08": 30316058,
"2026-10": 30312202,
"2026-11": 30310411
}
}
GET https://rankeez.com/api/medfinecapital.com.json · see API docs →
More about medfinecapital.com
medfinecapital.com — page content & similar sites →
幂方资本专注于医药健康与生命科学领域投资,总部在上海,北京创投联盟生物医药专业委员会创始会员。 公司控股上海幂方资产管理有限公司(备案编号: P1009348)、幂方资本管理(北京)有限公司(备案编号:P1020206),重点参股并联合发起设立上海诺瑾资产管理有限公司(FOF,备案编号: P1013936 ),拥有多家经中国证券投资基金业协会备案登记的私募投资基金管理公司。 公司业务遍布全国,在浙江、福建、江苏及江西等地设立及管理了多支股权投资基金。管理资金规模近10亿元,目前已经完成了十几家企业的投资与
medfinecapital.com — full site profile →
WHOIS, tech stack and extended traffic history for medfinecapital.com.